Tislelizumab, a novel PD-1 monoclonal antibody in urothelial cancer: A real-world study.
Wang Z, Bi H, Wang YD, Liu Q, Shao B, Li CQ, Fu C, Fu S, Shan GY, Chen A, Lv CC, Zeng Y.
Wang Z, et al. Among authors: shan gy.
Actas Urol Esp (Engl Ed). 2024 May;48(4):295-303. doi: 10.1016/j.acuroe.2023.12.006. Epub 2023 Dec 29.
Actas Urol Esp (Engl Ed). 2024.
PMID: 38160794
English, Spanish.